Compare PDLB & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDLB | XOMA |
|---|---|---|
| Founded | 1960 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.9M | 397.2M |
| IPO Year | 2017 | N/A |
| Metric | PDLB | XOMA |
|---|---|---|
| Price | $16.88 | $25.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $63.25 |
| AVG Volume (30 Days) | ★ 105.5K | 94.6K |
| Earning Date | 01-27-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.83 | N/A |
| EPS | ★ 0.89 | 0.82 |
| Revenue | ★ $96,252,000.00 | $47,106,000.00 |
| Revenue This Year | $10.97 | $77.29 |
| Revenue Next Year | $8.59 | $34.91 |
| P/E Ratio | ★ $19.00 | $31.63 |
| Revenue Growth | 26.04 | ★ 118.02 |
| 52 Week Low | $10.88 | $18.35 |
| 52 Week High | $18.01 | $39.92 |
| Indicator | PDLB | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 60.81 | 38.18 |
| Support Level | $16.87 | $24.81 |
| Resistance Level | $17.48 | $26.06 |
| Average True Range (ATR) | 0.43 | 1.54 |
| MACD | -0.00 | -0.16 |
| Stochastic Oscillator | 53.81 | 11.82 |
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.